Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 5
2005 5
2006 4
2007 5
2008 7
2009 11
2010 16
2011 21
2012 15
2013 12
2014 21
2015 11
2016 10
2017 15
2018 16
2019 21
2020 15
2021 8
2022 3
2023 1
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.
Nowak RJ, Benatar M, Ciafaloni E, Howard JF Jr, Leite MI, Utsugisawa K, Vissing J, Rojavin M, Li Q, Tang F, Wu Y, Rampal N, Cheng S; MINT Investigators. Nowak RJ, et al. N Engl J Med. 2025 Jun 19;392(23):2309-2320. doi: 10.1056/NEJMoa2501561. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202593 Clinical Trial.
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.
Oh J, Arnold DL, Cree BAC, Ionete C, Kim HJ, Sormani MP, Syed S, Chen Y, Maxwell CR, Benoit P, Turner TJ, Wallstroem E, Wiendl H; Tolebrutinib Phase 3 GEMINI 1 and 2 Trial Group. Oh J, et al. N Engl J Med. 2025 May 15;392(19):1893-1904. doi: 10.1056/NEJMoa2415985. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202623 Clinical Trial.
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
Anaerobic bacterial meningitis in adults.
Lee JJ, Lien CY, Chien CC, Huang CR, Tsai NW, Chang CC, Lu CH, Chang WN. Lee JJ, et al. Among authors: tsai nw. J Clin Neurosci. 2018 Apr;50:45-50. doi: 10.1016/j.jocn.2018.01.014. Epub 2018 Feb 1. J Clin Neurosci. 2018. PMID: 29396061
Sural nerve sensory response in diabetic distal symmetrical polyneuropathy.
Lai YR, Huang CC, Chiu WC, Liu RT, Tsai NW, Wang HC, Lin WC, Cheng BC, Su YJ, Su CM, Hsiao SY, Chang HW, Chen JF, Ko JY, Lu CH. Lai YR, et al. Among authors: tsai nw. Muscle Nerve. 2020 Jan;61(1):88-94. doi: 10.1002/mus.26739. Epub 2019 Nov 1. Muscle Nerve. 2020. PMID: 31614013
Bacterial meningitis in hemodialyzed patients.
Cheng BC, Chang WN, Lu CH, Chen JB, Chang CS, Lee CH, Lee CT, Chen TC, Pan HH, Hsu KT, Huang CR, Tsai NW, Chang CJ, Hung PL, Wang KW. Cheng BC, et al. Among authors: tsai nw. J Nephrol. 2004 Mar-Apr;17(2):236-41. J Nephrol. 2004. PMID: 15293523
Factors associated with fall-related fractures in Parkinson's disease.
Cheng KY, Lin WC, Chang WN, Lin TK, Tsai NW, Huang CC, Wang HC, Huang YC, Chang HW, Lin YJ, Lee LH, Cheng BC, Kung CT, Chang YT, Su CM, Chiang YF, Su YJ, Lu CH. Cheng KY, et al. Among authors: tsai nw. Parkinsonism Relat Disord. 2014 Jan;20(1):88-92. doi: 10.1016/j.parkreldis.2013.09.024. Epub 2013 Oct 1. Parkinsonism Relat Disord. 2014. PMID: 24134900
199 results